Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 12  •  04:00PM ET
211.58
Dollar change
+1.57
Percentage change
0.75
%
Dec 12, 8:30 PMU.S. FDA approves J&J’s AKEEGA for BRCA2-mutated metastatic castration-sensitive prostate cancer, expanding the label with data showing a 54% reduction in progression versus standard of care.
IndexDJIA, S&P 500 P/E20.42 EPS (ttm)10.36 Insider Own0.12% Shs Outstand2.41B Perf Week4.78%
Market Cap509.76B Forward P/E18.35 EPS next Y11.53 Insider Trans-7.63% Shs Float2.41B Perf Month8.84%
Enterprise Value536.99B PEG2.44 EPS next Q2.53 Inst Own74.47% Short Float0.99% Perf Quarter19.27%
Income25.12B P/S5.53 EPS this Y8.90% Inst Trans0.34% Short Ratio2.70 Perf Half Y34.68%
Sales92.15B P/B6.42 EPS next Y6.11% ROA13.54% Short Interest23.91M Perf YTD46.30%
Book/sh32.95 P/C27.46 EPS next 5Y7.53% ROE33.62% 52W High211.24 0.16% Perf Year41.78%
Cash/sh7.70 P/FCF26.01 EPS past 3/5Y-9.49% 0.55% ROIC21.16% 52W Low140.68 50.40% Perf 3Y19.42%
Dividend Est.5.19 (2.45%) EV/EBITDA17.24 Sales past 3/5Y-1.79% 1.58% Gross Margin68.27% Volatility2.09% 1.60% Perf 5Y42.03%
Dividend TTM5.14 (2.43%) EV/Sales5.83 EPS Y/Y TTM71.07% Oper. Margin25.79% ATR (14)3.39 Perf 10Y105.52%
Dividend Ex-DateNov 25, 2025 Quick Ratio0.80 Sales Y/Y TTM5.08% Profit Margin27.26% RSI (14)73.39 Recom2.04
Dividend Gr. 3/5Y5.43% 5.54% Current Ratio1.07 EPS Q/Q91.19% SMA203.65% Beta0.33 Target Price212.36
Payout84.80% Debt/Eq0.58 Sales Q/Q6.77% SMA508.11% Rel Volume0.78 Prev Close210.01
Employees139800 LT Debt/Eq0.50 EarningsOct 14 BMO SMA20023.49% Avg Volume8.86M Price211.58
IPOSep 25, 1944 Option/ShortYes / Yes EPS/Sales Surpr.1.54% 1.00% Trades Volume6,870,895 Change0.75%
Date Action Analyst Rating Change Price Target Change
Nov-13-25Initiated Scotiabank Sector Outperform $230
Oct-20-25Upgrade Daiwa Securities Neutral → Outperform $203
Oct-03-25Upgrade Wells Fargo Equal Weight → Overweight $212
Sep-23-25Upgrade Guggenheim Neutral → Buy $206
Jul-23-25Upgrade Erste Group Hold → Buy
May-13-25Downgrade Leerink Partners Outperform → Market Perform $153
Dec-10-24Resumed BofA Securities Neutral $166
Nov-15-24Initiated Wolfe Research Outperform $190
Jul-23-24Downgrade Daiwa Securities Outperform → Neutral $160 → $150
May-30-24Resumed Goldman Neutral $160
Dec-12-25 08:25PM
12:50PM
08:22AM
08:22AM
07:42AM
05:45PM Loading…
Dec-11-25 05:45PM
12:06PM
11:27AM
10:52AM
04:54AM
02:50AM
02:46AM
Dec-10-25 06:28PM
05:53PM
04:32PM
03:35PM Loading…
03:35PM
02:52PM
02:14PM
11:28AM
07:31AM
Dec-09-25 03:31PM
02:49PM
01:40PM
11:15AM
10:18AM
07:44AM
04:46AM
Dec-08-25 04:25PM
02:10PM
02:10PM
01:38PM Loading…
01:38PM
11:10AM
11:01AM
10:53AM
10:40AM
09:40AM
08:03AM
Dec-07-25 09:42AM
Dec-06-25 09:30AM
Dec-05-25 04:20PM
06:30AM
05:42AM
Dec-04-25 09:25PM
05:45PM
05:06PM
02:02PM
11:20AM
09:27AM
07:39AM
03:00AM
Dec-03-25 02:44PM
02:13PM
12:41PM
09:00AM
08:00AM
01:57AM
Dec-02-25 10:09AM
Dec-01-25 02:22PM
02:16PM
01:23PM
10:51AM
09:20AM
05:00AM
Nov-30-25 02:01PM
06:30AM
04:05AM
Nov-29-25 01:28PM
Nov-28-25 10:03AM
07:16AM
Nov-27-25 06:30AM
04:01AM
03:41AM
Nov-26-25 04:31PM
09:50AM
05:47AM
04:58AM
Nov-25-25 02:01PM
07:24AM
06:30AM
03:00AM
Nov-24-25 10:01PM
01:53PM
12:37PM
Nov-21-25 01:32PM
12:43PM
10:29AM
10:29AM
10:19AM
08:00AM
07:13AM
Nov-20-25 01:10PM
07:05AM
Nov-19-25 12:36PM
12:24PM
10:52AM
10:38AM
09:08AM
09:00AM
08:53AM
08:02AM
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MORIKIS JOHN GDirectorNov 26 '25Buy206.151,250257,6881,849Dec 01 04:15 PM
JOHNSON & JOHNSON10% OwnerNov 26 '25Sale10.036,33763,5604,040,861Dec 01 04:07 PM
JOHNSON & JOHNSON10% OwnerNov 24 '25Sale10.062,20022,1324,047,198Nov 25 12:54 PM
JOHNSON & JOHNSON10% OwnerNov 21 '25Sale10.005005,0004,049,398Nov 25 12:54 PM
JOHNSON & JOHNSON10% OwnerNov 12 '25Sale10.001,00010,0004,049,898Nov 14 03:07 PM
JOHNSON & JOHNSON10% OwnerNov 06 '25Sale10.2152,332534,3104,051,098Nov 10 03:28 PM
JOHNSON & JOHNSON10% OwnerNov 07 '25Sale10.002002,0004,050,898Nov 10 03:28 PM
REED JOHN CEVP, Innovative Medicine, R&DOct 17 '25Option Exercise157.9221,7213,430,18032,379Oct 20 07:13 PM
REED JOHN CEVP, Innovative Medicine, R&DOct 17 '25Sale192.7121,7214,185,79310,658Oct 20 07:13 PM
REED JOHN COfficerOct 17 '25Proposed Sale192.7121,7214,185,794Oct 17 10:23 AM
Taubert Jennifer LEVP, WWC. Innovative MedicineSep 04 '25Option Exercise101.8756,4715,752,701234,484Sep 05 06:00 PM
Taubert Jennifer LEVP, WWC. Innovative MedicineSep 04 '25Sale177.8156,47110,040,883178,013Sep 05 06:00 PM
Taubert Jennifer LOfficerSep 04 '25Proposed Sale177.8156,47110,040,904Sep 04 02:37 PM
Forminard ElizabethExecutive VP, General CounselAug 29 '25Option Exercise115.6711,5211,332,63422,423Sep 03 05:13 PM
Forminard ElizabethOfficerAug 29 '25Proposed Sale177.209,5701,695,806Aug 29 03:36 PM
Duato JoaquinCEO and Chairman of the BoardAug 22 '25Option Exercise101.87125,82412,817,691401,791Aug 25 07:12 PM
Duato JoaquinCEO and Chairman of the BoardAug 22 '25Sale179.21125,82422,548,655275,967Aug 25 07:12 PM
Duato JoaquinOfficerAug 22 '25Proposed Sale180.03125,82422,652,724Aug 22 01:58 PM
Wolk Joseph JExec VP, CFOAug 15 '25Option Exercise101.8716,8201,713,45330,820Aug 18 06:19 PM
Wolk Joseph JExec VP, CFOAug 15 '25Sale176.9116,8202,975,57114,000Aug 18 06:19 PM
Wolk Joseph JOfficerAug 15 '25Proposed Sale176.9116,8202,975,571Aug 15 03:57 PM
REED JOHN CEVP, Innovative Medicine, R&DJul 17 '25Sale163.5519,1373,129,83010,658Jul 18 04:12 PM
REED JOHN COfficerJul 17 '25Proposed Sale163.5519,1373,129,831Jul 17 04:05 PM
REED JOHN CEVP, Innovative Medicine, R&DMay 01 '25Option Exercise0.0025,255040,797May 05 05:10 PM
Decker Robert JVP Corporate ControllerFeb 25 '25Option Exercise101.876,999712,98828,000Feb 26 06:42 PM
Decker Robert JVP Corporate ControllerFeb 25 '25Sale165.886,9991,160,99421,001Feb 26 06:42 PM
Decker Robert JOfficerFeb 25 '25Proposed Sale165.886,9991,161,010Feb 25 03:05 PM
Schmid TimothyEVP, WW Chair, MedTechFeb 14 '25Option Exercise0.002,806017,904Feb 18 09:46 PM
Schmid TimothyEVP, WW Chair, MedTechFeb 15 '25Option Exercise0.001,029015,501Feb 18 09:33 PM
Schmid TimothyEVP, WW Chair, MedTechFeb 14 '25Option Exercise0.001,765015,111Feb 18 09:33 PM
Schmid TimothyEVP, WW Chair, MedTechFeb 13 '25Option Exercise0.00499013,539Feb 18 09:33 PM
Schmid TimothyEVP, WW Chair, MedTechFeb 18 '25Sale156.1540362,92815,098Feb 18 09:33 PM
Wengel Kathryn EEVP, Chief TO and Risk OfficerFeb 15 '25Option Exercise0.00607091,037Feb 18 09:16 PM
Wengel Kathryn EEVP, Chief TO and Risk OfficerFeb 14 '25Option Exercise0.007,367096,674Feb 18 09:16 PM
Wengel Kathryn EEVP, Chief TO and Risk OfficerFeb 13 '25Option Exercise0.00651089,603Feb 18 09:16 PM
Wolk Joseph JExec VP, CFOFeb 15 '25Option Exercise0.001,97106,113Feb 18 09:13 PM
Wolk Joseph JExec VP, CFOFeb 14 '25Option Exercise0.0019,330020,661Feb 18 09:13 PM
Wolk Joseph JExec VP, CFOFeb 13 '25Option Exercise0.001,77901,779Feb 18 09:13 PM
REED JOHN CEVP, Innovative Medicine, R&DFeb 15 '25Option Exercise0.001,350015,927Feb 18 09:11 PM
Taubert Jennifer LEVP, WWC. Innovative MedicineFeb 15 '25Option Exercise0.001,5940171,110Feb 18 09:08 PM
Taubert Jennifer LEVP, WWC. Innovative MedicineFeb 14 '25Option Exercise0.0019,5180185,924Feb 18 09:08 PM
Taubert Jennifer LEVP, WWC. Innovative MedicineFeb 13 '25Option Exercise0.001,3020167,221Feb 18 09:08 PM
Swanson James D.EVP, CIOFeb 15 '25Option Exercise0.00492016,762Feb 18 09:06 PM
Swanson James D.EVP, CIOFeb 14 '25Option Exercise0.005,079019,739Feb 18 09:06 PM
Swanson James D.EVP, CIOFeb 13 '25Option Exercise0.00447015,019Feb 18 09:06 PM
Mulholland KristenEVP, Chief HR OfficerFeb 15 '25Option Exercise0.00419013,095Feb 18 09:05 PM
Mulholland KristenEVP, Chief HR OfficerFeb 14 '25Option Exercise0.002,608014,576Feb 18 09:05 PM
Mulholland KristenEVP, Chief HR OfficerFeb 13 '25Option Exercise0.00411012,100Feb 18 09:05 PM
Forminard ElizabethExecutive VP, General CounselFeb 15 '25Option Exercise0.00961010,321Feb 18 09:03 PM
Forminard ElizabethExecutive VP, General CounselFeb 14 '25Option Exercise0.002,203011,366Feb 18 09:03 PM
Forminard ElizabethExecutive VP, General CounselFeb 13 '25Option Exercise0.0065108,991Feb 18 09:03 PM
Duato JoaquinCEO and Chairman of the BoardFeb 15 '25Option Exercise0.003,6820397,525Feb 18 09:02 PM
Duato JoaquinCEO and Chairman of the BoardFeb 14 '25Option Exercise0.0024,3350415,205Feb 18 09:02 PM
Duato JoaquinCEO and Chairman of the BoardFeb 13 '25Option Exercise0.003,4700392,498Feb 18 09:02 PM
Decker Robert JVP Corporate ControllerFeb 15 '25Option Exercise0.00339020,116Feb 18 09:01 PM
Decker Robert JVP Corporate ControllerFeb 14 '25Option Exercise0.002,201021,373Feb 18 09:01 PM
Decker Robert JVP Corporate ControllerFeb 13 '25Option Exercise0.00312019,285Feb 18 09:01 PM
Broadhurst VanessaEVP, Global Corp AffairsFeb 15 '25Option Exercise0.00492021,839Feb 18 08:58 PM
Broadhurst VanessaEVP, Global Corp AffairsFeb 14 '25Option Exercise0.004,740024,591Feb 18 08:58 PM
Broadhurst VanessaEVP, Global Corp AffairsFeb 13 '25Option Exercise0.00408020,242Feb 18 08:58 PM
Duato JoaquinCEO and Chairman of the BoardFeb 07 '25Option Exercise100.06126,36912,644,482489,671Feb 11 07:43 PM
Wengel Kathryn EEVP, Chief TO and Risk OfficerFeb 07 '25Option Exercise100.0632,7623,278,166115,028Feb 11 07:42 PM
Taubert Jennifer LEVP, WWC. Innovative MedicineFeb 07 '25Option Exercise100.0658,5045,853,910213,355Feb 11 07:41 PM
Wolk Joseph JExec VP, CFOFeb 07 '25Option Exercise100.0613,0151,302,28113,015Feb 11 07:40 PM
Wolk Joseph JExec VP, CFOFeb 07 '25Sale153.8913,0152,002,8780Feb 11 07:40 PM
Wolk Joseph JOfficerFeb 07 '25Proposed Sale153.8913,0152,002,924Feb 07 01:27 PM
Last Close
Dec 12  •  04:00PM ET
328.69
Dollar change
-0.61
Percentage change
-0.19
%
SHW Sherwin-Williams Co daily Stock Chart
IndexDJIA, S&P 500 P/E32.10 EPS (ttm)10.24 Insider Own7.23% Shs Outstand247.90M Perf Week-1.33%
Market Cap81.48B Forward P/E26.19 EPS next Y12.55 Insider Trans-0.01% Shs Float229.96M Perf Month-4.65%
Enterprise Value95.63B PEG3.49 EPS next Q2.16 Inst Own83.66% Short Float1.89% Perf Quarter-7.95%
Income2.57B P/S3.50 EPS this Y0.43% Inst Trans-0.39% Short Ratio2.22 Perf Half Y-2.14%
Sales23.28B P/B18.41 EPS next Y10.28% ROA10.25% Short Interest4.34M Perf YTD-3.31%
Book/sh17.85 P/C337.39 EPS next 5Y7.51% ROE59.94% 52W High379.65 -13.42% Perf Year-11.55%
Cash/sh0.97 P/FCF33.58 EPS past 3/5Y14.77% 13.93% ROIC15.99% 52W Low308.84 6.43% Perf 3Y30.89%
Dividend Est.3.13 (0.95%) EV/EBITDA21.41 Sales past 3/5Y5.02% 5.23% Gross Margin48.88% Volatility1.85% 1.90% Perf 5Y38.87%
Dividend TTM3.16 (0.96%) EV/Sales4.11 EPS Y/Y TTM1.96% Oper. Margin16.38% ATR (14)6.37 Perf 10Y261.97%
Dividend Ex-DateNov 14, 2025 Quick Ratio0.52 Sales Y/Y TTM0.96% Profit Margin11.05% RSI (14)43.70 Recom2.04
Dividend Gr. 3/5Y9.14% 13.63% Current Ratio0.82 EPS Q/Q5.37% SMA20-1.36% Beta1.26 Target Price391.63
Payout27.10% Debt/Eq3.25 Sales Q/Q3.18% SMA50-2.29% Rel Volume0.83 Prev Close329.30
Employees63890 LT Debt/Eq2.64 EarningsOct 28 BMO SMA200-5.00% Avg Volume1.96M Price328.69
IPOJul 02, 1962 Option/ShortYes / Yes EPS/Sales Surpr.4.07% 2.47% Trades Volume1,632,932 Change-0.19%
Date Action Analyst Rating Change Price Target Change
Aug-14-25Upgrade BofA Securities Underperform → Neutral $375
Jun-13-25Downgrade Citigroup Buy → Neutral $385
Mar-10-25Downgrade Jefferies Buy → Hold $423 → $380
Feb-26-25Resumed Citigroup Buy $418 → $423
Jan-24-25Upgrade Berenberg Hold → Buy $321 → $420
Oct-07-24Downgrade KeyBanc Capital Markets Overweight → Sector Weight
Jul-24-24Reiterated Evercore ISI Outperform $360 → $365
Apr-25-24Upgrade KeyBanc Capital Markets Sector Weight → Overweight $400
Mar-07-24Upgrade UBS Neutral → Buy $312 → $402
Mar-01-24Initiated Wolfe Research Peer Perform
Dec-11-25 10:05AM
10:04AM
Dec-09-25 01:21PM
Dec-08-25 10:53AM
Dec-04-25 11:30AM
11:30AM Loading…
Nov-27-25 11:30AM
Nov-25-25 09:14AM
Nov-24-25 02:03PM
Nov-21-25 04:32PM
03:27PM
12:35PM
Nov-14-25 10:58AM
Nov-13-25 10:32PM
Nov-12-25 07:59AM
Nov-08-25 12:39AM
07:22PM Loading…
Nov-07-25 07:22PM
04:41PM
03:27PM
02:18PM
Nov-04-25 07:17PM
12:36AM
Nov-03-25 11:53PM
04:15PM
09:18AM
Nov-02-25 07:35PM
Oct-30-25 03:16PM
08:02AM
Oct-29-25 01:32AM
Oct-28-25 05:01PM
03:41PM
02:02PM Loading…
02:02PM
01:57PM
01:20PM
12:31PM
12:11PM
11:49AM
10:37AM
09:30AM
08:28AM
08:10AM
07:39AM
07:07AM
07:00AM
Oct-27-25 11:54AM
Oct-26-25 11:11PM
07:43AM
Oct-24-25 05:10PM
03:19PM
Oct-23-25 06:10PM
10:00AM
09:15AM
Oct-21-25 04:05PM
10:55AM
10:00AM
Oct-10-25 10:34AM
Oct-09-25 11:42PM
11:28AM
Oct-06-25 12:14PM
10:35AM
09:34AM
Oct-01-25 04:15PM
01:33PM
Sep-30-25 08:00AM
Sep-28-25 07:59PM
Sep-26-25 12:26PM
Sep-25-25 03:59PM
Sep-24-25 08:57AM
Sep-21-25 10:57AM
Sep-20-25 09:40AM
Sep-17-25 03:53PM
12:42PM
09:18AM
Sep-15-25 01:44PM
Sep-12-25 02:45PM
06:04AM
Sep-11-25 07:50PM
01:47PM
10:53AM
Sep-09-25 12:18PM
Sep-07-25 11:31PM
Sep-04-25 06:20AM
Aug-29-25 09:13AM
Aug-28-25 11:30AM
Aug-25-25 12:11PM
10:53AM
Aug-23-25 06:05PM
Aug-22-25 01:56PM
Aug-21-25 11:30AM
Aug-19-25 10:35AM
12:04AM
Aug-17-25 05:07PM
Aug-16-25 04:00AM
Aug-14-25 09:40AM
08:03AM
Aug-13-25 11:32PM
Aug-12-25 07:01PM
Aug-06-25 05:10AM
Aug-05-25 08:30AM
Aug-04-25 09:00AM
Aug-02-25 12:00PM
The Sherwin-Williams Co. engages in the development, manufacture, distribution, and sale of paint and coatings. It operates through the following segments: Paint Stores Group, Consumer Brands Group, Performance Coatings Group, and Administrative. The Paint Stores Group segment caters to the needs of architectural and industrial paint contractors and do-it-yourself homeowners. The Consumer Brands Group segment manufactures and distributes a broad portfolio of branded and private-label architectural paint, stains, varnishes and other industrial products. The Performance Coatings Group segment develops and sells industrial coatings for wood finishing and general industrial applications. The Administrative segment refers to the administrative expenses and assets of the company's new global headquarters and research and development center, both currently under construction. The company was founded by Henry Sherwin and Edward Williams in 1866 and is headquartered in Cleveland, OH.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Mistysyn Allen JSVP - Finance & CFODec 01 '25Option Exercise249.11802199,78813,562Dec 03 06:20 PM
Binns Justin TPresident, Glob. ArchitecturalAug 25 '25Option Exercise79.8560948,62918,531Aug 27 04:35 PM
Binns Justin TPresident, Glob. ArchitecturalAug 25 '25Sale368.82609224,61117,922Aug 27 04:35 PM
Binns Justin TOfficerAug 25 '25Proposed Sale368.82609224,612Aug 25 10:22 AM
Lang James P.SVP - Enterprise Finance & CAOAug 06 '25Option Exercise186.85860160,6911,237Aug 08 08:05 AM
Lang James P.SVP - Enterprise Finance & CAOAug 06 '25Sale350.35860301,301377Aug 08 08:05 AM
Lang James P.OfficerAug 06 '25Proposed Sale350.35860301,301Aug 06 11:56 AM
Rea Todd DPresident, Consumer Brands GrpJun 06 '25Option Exercise236.642,686635,62813,552Jun 10 04:07 PM
Rea Todd DPresident, Consumer Brands GrpJun 06 '25Sale359.164,2231,516,7339,329Jun 10 04:07 PM
Rea Todd DOfficerJun 06 '25Proposed Sale359.164,2231,516,745Jun 06 04:17 PM
Davie Colin M.Pres. & GM, Glob. Supply ChainFeb 27 '25Sale360.302,7991,008,4915,365Mar 03 11:42 AM
Davie Colin M.OfficerFeb 27 '25Proposed Sale360.302,7991,008,491Feb 27 02:10 PM
Last Close
Dec 12  •  04:00PM ET
46.69
Dollar change
+0.46
Percentage change
1.00
%
GIS General Mills, Inc daily Stock Chart
IndexS&P 500 P/E8.84 EPS (ttm)5.28 Insider Own0.39% Shs Outstand534.70M Perf Week1.65%
Market Cap24.91B Forward P/E12.32 EPS next Y3.79 Insider Trans-0.19% Shs Float531.33M Perf Month0.41%
Enterprise Value38.37B PEG- EPS next Q1.02 Inst Own86.40% Short Float5.54% Perf Quarter-4.73%
Income2.91B P/S1.30 EPS this Y-13.28% Inst Trans-0.25% Short Ratio4.78 Perf Half Y-12.83%
Sales19.16B P/B2.63 EPS next Y3.81% ROA8.98% Short Interest29.42M Perf YTD-26.78%
Book/sh17.78 P/C26.14 EPS next 5Y-1.41% ROE30.98% 52W High67.35 -30.68% Perf Year-29.41%
Cash/sh1.79 P/FCF11.88 EPS past 3/5Y-2.48% 2.88% ROIC13.39% 52W Low45.15 3.41% Perf 3Y-46.47%
Dividend Est.2.44 (5.23%) EV/EBITDA10.32 Sales past 3/5Y0.86% 2.03% Gross Margin34.47% Volatility1.71% 1.94% Perf 5Y-21.84%
Dividend TTM2.42 (5.18%) EV/Sales2.00 EPS Y/Y TTM25.59% Oper. Margin16.60% ATR (14)0.88 Perf 10Y-20.22%
Dividend Ex-DateJan 09, 2026 Quick Ratio0.40 Sales Y/Y TTM-3.26% Profit Margin15.19% RSI (14)49.19 Recom2.83
Dividend Gr. 3/5Y5.57% 4.13% Current Ratio0.66 EPS Q/Q115.80% SMA20-0.19% Beta-0.07 Target Price52.44
Payout58.56% Debt/Eq1.52 Sales Q/Q-6.82% SMA50-1.63% Rel Volume0.98 Prev Close46.23
Employees33000 LT Debt/Eq1.29 EarningsDec 17 BMO SMA200-10.50% Avg Volume6.16M Price46.69
IPONov 30, 1928 Option/ShortYes / Yes EPS/Sales Surpr.5.08% -0.44% Trades Volume6,043,321 Change1.00%
Date Action Analyst Rating Change Price Target Change
Aug-20-25Downgrade JP Morgan Neutral → Underweight $45
Jun-26-25Upgrade RBC Capital Mkts Sector Perform → Outperform $63
Jun-09-25Downgrade Goldman Buy → Neutral $58
Apr-23-25Initiated UBS Sell $54
Mar-24-25Initiated Morgan Stanley Underweight $53
Mar-10-25Reiterated Jefferies Hold $58 → $62
Dec-19-24Reiterated TD Cowen Hold $75 → $64
Dec-13-24Upgrade BofA Securities Neutral → Buy $78 → $80
Aug-12-24Initiated Goldman Buy $76
Jul-16-24Downgrade Argus Buy → Hold
Today 08:55AM
Dec-12-25 10:00AM
09:15AM
Dec-10-25 10:00AM
Dec-09-25 09:53AM
03:42PM Loading…
Dec-08-25 03:42PM
11:00AM
Dec-05-25 04:21PM
Dec-04-25 09:00AM
07:40AM
Dec-02-25 04:29PM
01:55PM
01:33PM
Dec-01-25 05:58AM
Nov-21-25 09:07AM
08:00AM Loading…
Nov-19-25 08:00AM
Nov-18-25 06:14PM
Nov-17-25 04:30PM
Nov-16-25 11:38PM
Nov-13-25 12:09PM
Nov-10-25 07:30PM
11:22AM
10:41AM
Nov-07-25 05:45PM
05:00AM
Nov-06-25 08:17PM
01:47AM
Nov-05-25 04:30PM
Nov-02-25 01:07PM
Oct-31-25 12:25PM
09:45AM Loading…
Oct-29-25 09:45AM
Oct-23-25 09:35AM
12:01AM
Oct-20-25 09:15AM
09:00AM
06:39AM
06:00AM
Oct-16-25 10:57AM
Oct-15-25 11:40AM
Oct-14-25 07:59PM
08:00AM
Oct-13-25 08:38PM
01:02PM
11:46AM
Oct-09-25 10:52PM
09:00AM
Oct-08-25 11:42AM
07:16AM
Oct-06-25 12:35AM
Oct-05-25 05:30AM
Oct-03-25 05:11PM
02:30PM
10:59AM
Oct-02-25 11:59PM
04:54PM
12:12PM
10:00AM
05:55AM
12:26AM
Oct-01-25 01:16PM
07:52AM
06:25AM
05:32AM
Sep-30-25 09:17AM
09:00AM
07:00AM
Sep-29-25 04:14PM
01:18PM
Sep-27-25 04:15AM
Sep-26-25 02:32AM
Sep-24-25 11:46AM
01:30AM
12:36AM
Sep-23-25 11:00AM
05:52AM
12:32AM
Sep-22-25 02:05PM
09:05AM
Sep-19-25 08:22PM
09:57AM
Sep-18-25 07:04PM
08:29AM
08:12AM
06:27AM
03:01AM
01:30AM
Sep-17-25 05:15PM
04:35PM
04:10PM
04:00PM
02:56PM
02:56PM
02:25PM
02:09PM
01:49PM
01:03PM
11:51AM
10:54AM
09:44AM
09:41AM
General Mills, Inc. engages in the manufacture and marketing of branded consumer foods sold through retail stores. Its product categories include snacks, ready-to-eat cereal, convenient meals, pet food, refrigerated and frozen dough, baking mixes and ingredients, yogurt, and ice cream. It operates through the following segments: North America Retail, International, North America Pet, and North America Foodservice. The North America Retail segment includes grocery stores, mass merchandisers, membership stores, natural food chains, drug, dollar and discount chains, convenience stores, and e-commerce grocery providers. The International segment refers to the retail and foodservice businesses outside of the US and Canada. The North America Pet segment includes pet food products sold in national pet superstore chains, e-commerce retailers, grocery stores, regional pet store chains, mass merchandisers, and veterinary clinics and hospitals. The North America Foodservice segment offers ready-to-eat cereals, snacks, refrigerated yogurt, frozen meals, unbaked and fully baked frozen dough products, baking mixes, and bakery flour. The company was founded by Cadwallader C. Washburn on June 20, 1928 and is headquartered in Minneapolis, MN.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Williams-Roll JacquelineChief Human Resources OfficerSep 19 '25Sale50.044,000200,15666,593Sep 23 02:16 PM
Williams-Roll JacquelineOfficerSep 19 '25Proposed Sale50.014,000200,036Sep 19 11:11 AM
MARY JANE MELENDEZOfficerSep 12 '25Proposed Sale50.081,62981,572Sep 12 04:29 PM
MARY JANE MELENDEZOfficerAug 14 '25Proposed Sale49.5413,040646,002Aug 14 06:28 PM
JONATHON NUDIOfficerAug 11 '25Proposed Sale49.2819,136943,006Aug 11 06:16 PM
JONATHON NUDIOfficerJul 02 '25Proposed Sale53.686,000322,062Jul 02 05:18 PM
Sharma Pankaj MNSegment PresidentMay 15 '25Sale54.123,643197,15933,073May 19 04:02 PM
PANKAJ SHARMAOfficerMay 15 '25Proposed Sale54.123,643197,159May 15 05:21 PM
HARMENING JEFFREY LChairman of the Board & CEOMar 07 '25Option Exercise55.7211,379634,038364,725Mar 10 03:46 PM
HARMENING JEFFREY LChairman of the Board & CEOMar 07 '25Sale65.0011,379739,635353,346Mar 10 03:46 PM
JEFFREY HARMENINGOfficerMar 07 '25Proposed Sale65.0011,379739,635Mar 07 05:22 PM
Gallagher Paul JosephChief Supply Chain OfficerDec 20 '24Sale64.501,04167,14442,117Dec 23 02:14 PM
Gallagher Paul JosephOfficerDec 20 '24Proposed Sale64.501,04167,144Dec 20 05:10 PM